Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

REduCing Immunogenicity to PegloticasE (RECIPE) Study

Trial Profile

REduCing Immunogenicity to PegloticasE (RECIPE) Study

Phase of Trial: Phase II

Latest Information Update: 03 Nov 2018

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Pegloticase (Primary)
  • Indications Gout
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Acronyms RECIPE
  • Most Recent Events

    • 30 May 2018 Status changed from not yet recruiting to recruiting.
    • 26 Apr 2018 Planned initiation date changed from 15 Apr 2018 to 15 May 2018.
    • 09 Mar 2018 Planned initiation date changed from 1 Mar 2018 to 15 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top